Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8519357 | Contemporary Clinical Trials Communications | 2018 | 8 Pages |
Abstract
In selected fields, there has been a modest temporal increase in single race/ethnicity inclusion requirements. Some studies may not fall under regulatory purview and hence may be less likely to include diverse samples. Conversely, some eligibility requirements may be related to health disparities research. Future work should examine whether targeted enrollment criteria facilitates development of personalized medicine or reduces trial access.
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmaceutical Science
Authors
Brian L. Egleston, Omar Pedraza, Yu-Ning Wong, Candace L. Griffin, Eric A. Ross, J. Robert Beck,